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HIV-replication.5-13 Mathematical models show that repeated 
malaria infections can be associated with elevated HIV 
viral loads, which in turn increase transmission potential 
and thereby amplify HIV prevalence.1Growing evidence 
suggests that prevention of  malaria in HIV-infected persons 
may be a useful strategy for the prevention of  HIV infection, 
in addition to the direct benefits of  reduced malaria-
related morbidity and mortality.1,2 In Uganda, a strategy of  
cotrimoxazole prophylaxis, antiretroviral therapy (ART) 
and insecticide treated bednets (ITN) reduced the baseline 
malaria prevalence in HIV-infected persons by 95%, from 51 
episodes per 100 person-years to 2 episodes per 100 person-
years.14 While the scale up of  cotrimoxazole prophylaxis and 
ITNs is moving relatively slowly in sub-Saharan Africa, ART 
is being massively scaled up. For example, at the end of  2005 
there were 810,000 people estimated to have been started 
on this life-saving medication in the region compared with a 
baseline of  about 20,000 a few years earlier.15
Malawi is one of  the countries in sub-Saharan Africa making 
good progress with ART scale up.3 In January 2004, 9 
facilities in the public sector were providing ART to about 
4,000 patients, and by December 2006, there were 104 public 
sector ART facilities and 82,001 patients started on ART 
(source- HIV Unit, Ministry of  Health, Malawi). Scale-up 
of  cotrimoxazole prophylaxis is planned to begin in 2007, 
initially at facilities that provide ART.16
In Malawi, where Plasmodium falciparum is holoendemic, 
a number of  efforts are underway to scale-up malaria 
prevention and treatment for targeted groups. ITNs have 
been demonstrated to reduce malaria transmission rates and 
malaria-associated morbidity, particularly in key risk groups 
such as young children and pregnant women.17-19 Using funds 
from its Round 2 Global Fund (GFATM) Malaria Award 
and anticipated funding from the U.S. President’s Malaria 
Initiative (PMI), Malawi plans to scale-up the distribution of  
ITNs through antenatal clinics, clinics for young children (<5 
years old), immunization clinics, and community venues to 
increase net coverage.20-22 This will be accompanied by mass 
media and community-based interventions to increase year-
round use of  ITNs.23 HIV-infected patients, however, have 
not yet been targeted for ITN distribution at health facilities 
in malaria prevention efforts.
In Malawi, where ART delivery is carried out in a simple, 
standardised way, we believe that this system can also be used 
to deliver ITNs to a large number of  HIV-infected persons.24-
26 We therefore set up a pilot project to test the feasibility 
of  integrating ITN provision in three facilities that provide 
ART in the central region of  Malawi.
Methods
Routine Patient Monitoring and Data Collection
The process of  ART scale-up and delivery in Malawi in the 
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HIV infection and malaria, two of  the most common and 
important health problems in sub-Saharan Africa, have 
been demonstrated to have interactive pathology. In Malawi, 
where malaria is endemic, and antiretroviral therapy (ART) 
delivery is scaling up, we piloted integration of  long-lasting 
insecticide-treated bednets (ITN) provision in three ART 
clinics. In July 2006, 1,910 ITNs were delivered to pilot 
sites, and ART clinic staff  personnel were briefed on ITN 
provision and use of  a monitoring system. Sites were assessed 
using a structured questionnaire in December 2006. During 
the pilot period, 1,282 ITNs were distributed to patients. 
A large proportion (70%) of  ART patients at these sites 
received pilot study ITNs. Site adherence to the monitoring 
system was variable. Seventeen patients were interviewed, 14 
of  whom were ART patients who had received ITNs; 11 
of  these (79%) had slept under the net the previous night. 
This pilot demonstrates the feasibility of  ITN distribution to 
patients attending ART clinics in Malawi. Programmatic and 
policy considerations for national roll-out include the need 
to: 1) adopt a standardized monitoring system, 2) develop 
information, education, and communication materials, 3) 
develop in-service training for ART clinicians, and 4) identify 
systems for forecasting, procuring and distributing ITNs.
Introduction
Infection with the human immunodeficiency virus (HIV) 
and Plasmodium falciparum are the two most common and 
important health problems in sub-Saharan Africa.1-3 To the 
estimated 26 million adults and children already infected 
with HIV in this region, every year another 3 million people 
become newly infected and 2.5 million people die of  HIV-
related disease or AIDS.3 In addition, there are between 300 - 
500 million clinical Plasmodium falciparum infections every year, 
with more than a million malaria-associated deaths.4 There is 
considerable geographical overlap between the two diseases, 
and growing evidence of  interactive pathology.1,2 HIV 
increases the risk of  malaria infection and the development 
of  clinical malaria and severe disease, while malaria induces 
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public sector has already been described, and only the main 
elements will be presented below. ART is provided free of  
charge in public sector facilities to HIV-infected patients who 
are eligible for ART.23-25 HIV-positive patients are eligible for 
ART if  they are assessed to be in WHO Clinical Stage 3 or 4, 
or have a CD4-lymphocyte count < 250/mm3 or in the case 
of  children have a CD4 count below the threshold value.26 All 
ART facilities use a standard approach, which includes: a focus 
on the use of  one generic, fixed-dose combination treatment 
with stavudine, lamivudine and nevirapine; a standardised 
system of  registration, monitoring and reporting of  cases 
and outcomes; and quarterly supervision and evaluation of  
all ART sites. Eligible patients are started on ART, seen two 
weeks later, and then monthly, with assessments and drugs 
being distributed from ART clinics.
When a patient is first registered for ART, he/she is given a 
unique ART registration number and vital data are recorded 
using two standardised monitoring tools: the ART patient 
master card and the ART register.24,25 These monitoring tools 
are kept in the ART clinic, while the patient also keeps an 
ART identity card, in which is recorded the unique ART 
registration number and other vital information pertaining 
to ART. Patient details, which are entered into the master 
card and register, include age, sex, date and place of  HIV 
test, reason for starting ART and the drug formulation. 
Every month the patient comes for review and standardised 
outcomes and follow-up details are recorded monthly on 
master cards; these master cards are used to update the 
follow-up status for each patient in the ART register each 
quarter.
The HIV Unit of  the Ministry of  Health, Malawi, and its 
partners conduct quarterly supervisory and monitoring visits 
to all ART public sector sites in the country. The monitoring 
teams check the accuracy, completeness and consistency of  
the register and compare master card details with entries 
to the register. A quarterly cohort analysis is performed 
on the most recent 3-month cohort of  patients started on 
ART and the cumulative cohort of  patients ever started on 
therapy, with outcomes censored at the end of  the respective 
quarter.25
Provision of  ITNs to patients attending the ART 
clinics in 3 pilot sites
In early 2006, the Ministry of  Health, along with key 
stakeholders including the National Malaria Control 
Program, the Centres for Disease Control and Prevention 
(CDC), and UNICEF initiated a pilot study. The objective 
was to provide long-lasting ITNs (PermaNet®; purchased 
with CDC funding) to the ART clinics for staff  to distribute 
free to new patients starting ART as well as to patients alive 
and coming for follow-up who had not received an ITN.
Three ART facilities in the Central Region of  Malawi (Dedza 
District Hospital, Salima District Hospital and Kamuzu 
Central Hospital [KCH] Paediatric Clinic) were selected for 
the pilot study. As medium burden (defined as starting 50 
new patients on ART per month) Ministry of  Health ART 
facilities that do not receive external assistance, these sites 
were selected as they were considered “typical” of  other 
medium burden ART sites in Malawi. The geographic 
proximity of  the sites to the capital city of  Lilongwe allowed 
for periodic monitoring of  implementation during the pilot 
phase.
A total of  1,910 ITNs were distributed by MOH staff  
directly to the ART clinic for the pilot study. ART clinic 
personnel were briefed by staff  from the Ministry of  Health 
and implementing partners involved with quarterly ART site 
supervision about how to provide ITNs and use a sticker 
system for tracking ITN distribution, monitoring and 
evaluation. ART clinic personnel were also invited to take up 
to two ITNs for themselves as a benefit of  the program.
Monitoring and Evaluation System
ITNs were distributed to the three sites between July and 
August 2006. An ITN sticker book was provided to each site. 
This book had several pages of  rows of  sticker numbers, 
starting at row 1 and continuing up to row 1,000. Each row 
had a unique number with five numbered stickers which were 
to be removed and stuck on: a) the patient’s ART master 
card, b) the patient’s row in the ART register, c) the ITN 
register, which included the date of  provision of  the ITN, 
the name and ART number of  the patient, d) the patient’s 
health passport, and e) a sticker to remain in the sticker 
book for record keeping. This system allowed the patient 
who had been given an ITN to be identified within the ART 
monitoring system.
Data collection and analysis
ART site evaluation visits took place in December 2006 and, 
using a structured questionnaire, data were collected on a) 
quantitative aspects of  ITN provision, b) education and 
information provided to patients, c) storage of  ITNs, and 
d) qualitative aspects about provision of  ITNs from patient 
interviews. Data was entered and analysed in an EXCEL 
spread sheet.
Ethical approval
General measures are provided in all ART facilities to 
ensure patient confidentiality, consent for HIV testing, and 
counselling and support for those who receive a positive 
HIV test result. Specific data collected for this analysis did 
not include personal identifiers. The Malawi National Health 
Science Research Committee provides general oversight and 
approval for the collection and use of  routine programmatic 
data for monitoring and evaluation.
Results
Receipt, distribution and storage of  ITNs
Data on the number of  ITNs received and distributed, 
the remaining stock, the number unaccounted for and the 
number of  patients alive and on ART as of  September 
30th 2006 are shown in Table 1. Using the ITN Register 
as the gold standard, there were 1,282 ITNs distributed to 
patients from July 2006 until the time of  the visit. The total 
number of  patients alive and on ART at these sites by end 
of  September 2006 was 1,821, so a good proportion (70.4%) 
of  these received ITNs. An additional 35 bed nets were 
recorded to have been distributed to the health care workers 
at the facilities.
In terms of  monitoring the distribution of  ITNs, some 
variance was observed in sites’ adherence to the monitoring 
system. In Dedza District Hospital there was 100% 
concurrence with stickers placed on all monitoring tools. 
However, distribution of  ITNs to health care workers was 
recorded in a separate book, and there were 20 (4%) ITNs 
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not accounted for. In Salima District Hospital there was 
concurrence between stickers placed in the ITN Register and 
in master cards, but there was a smaller number of  stickers 
placed in the ART register due to the ART clerk forgetting 
to do this. All ITNs were accounted for at the Salima District 
Hospital site. In KCH Paediatric Clinic, ITNs were given to 
any HIV-infected person attending the clinic and not just 
ART patients. ITN sticker numbers had not been placed 
in the ART Register or the ART Patient master card, but 
instead had been placed in a separate patient filing system 
used by a non-governmental organization (NGO) that works 
in the clinic and it was therefore impossible to know how 
many ART patients had received bed nets. Record keeping 
was further compromised by the use of  a parallel identity 
system making it difficult to link patients in the ITN register 
(which listed IDs from the parallel ID system) with records 
of  ART patients in the patient master cards and register (that 
are based on the national ART ID system). There was no 
record of  ITNs being given to health care workers. There 
were 9 ITNs (1%) not accounted for.
In the two district hospitals, the ITNs were stored in the 
hospital bulk stores room, while in KCH they were stored 
in the pharmacy. All ITNs were distributed from sub-stocks 
in the ART clinics. None of  the hospitals had any formal 
written material on use of  ITNs, and the education provided 
to patients was of  a verbal nature usually given during 
group counselling ART sessions and individual counselling 
at the start of  ART. All of  the ART staff  welcomed the 
introduction of  ITNs in the clinic. Although they initially 
found it additional work, they adjusted to the use of  stickers, 
they felt they were offering an additional and welcome service 
for their patients, and the patients were very positive about 
receiving free ITNs.
Patients’ perspectives on ITNs
A convenience sample of  17 patients was interviewed in 
the sites. Of  the 17 patients, 15 had received ITNs, and 14 
were patients on ART. Details about interviews with the 15 
patients are shown in Table 2. There were 4 patients who 
did not sleep under the ITN the previous night, the reasons 
reported being: the ITN had been burnt (2), the ITN had been 
stolen (1) and the ITN had been used by a family member 
other than the patient (1). The 11 patients who had slept 
under the net the previous night also reported that a total of  
26 individuals (11 ART patients and an additional 15 family 
members) had slept under the same net the previous night, 
suggesting an added protective benefit to family members 
against malaria.
Discussion
This pilot study shows that it is feasible to distribute ITNs 
to patients attending ART clinics, that this intervention did 
not disrupt primary service delivery, and was welcomed by 
patients, who in general used the ITNs according to education 
by care providers. However, there were some important 
lessons learnt in the pilot that will need to be incorporated 
into practice and policy:
During initial scale-up, policy must be clarified to ensure 
that in ART clinics, ITNs are for ART patients only and 
not for other HIV-infected persons currently ineligible 
for ART. Eventually, provision of  ITNs may be extended 
to include other HIV-infected individuals; however those 
with advanced clinical stage and/or CD4 cell count <250 
should be prioritized. In the future, in order to establish 
a system of  ITN distribution to prioritized groups of  
HIV patients not yet eligible for ART, a system for 
distributing ITNs (e.g in outpatient clinics), as well as 
tools for monitoring ITN distribution, would need to be 
developed. Expansion of  the program to include pre-
ART HIV patients, such as those attending VCT sites, 
and especially inclusion in home-based care kits, should 
be considered following the national roll-out of  ITNs to 
ART patients.
A standardized monitoring system needs to be adopted 
by ART clinics and ITN distribution monitored during 
routine supervisory visits. Specifically,




Table 1: Receipt, distribution and stocks of  insecticide treated bed nets 








Number ITN bed nets 
received (Bulk store record)
505 505 900 1910
Number ITN bed nets given 
to patients (ITN Register)
466 316 500 1282
Number ITN bednets given 
to health care workers 
(separate record)
18 17 0 35
Number ITN bed nets in
stock
1 172 391 564
Number ITN bednets 
unaccounted
20 0 9 29
Comparison of Number ITN bednets given to patients ( by source 
information)
Number ITN bednets given 
to patients (ITN Register)
466 316 500 1282
Number ITN bednets given 
to patients (ART 
Mastercards)
466 316 no record
Number ITN bednets given 
to patients (ART Register) 
466 306 no record
Number ITN bednets given 
to patients (ITN sticker
 books)
466 324 500 1290
Number ART patients alive 
on ART by Sep 30, 2006
541 829 451 1821
KCH = Kamuzu Central Hospital
DH = District Hospital
ITN = Insecticide treated bed net
ART = antiretroviral therapy






Patient monitoring tools (i.e. 
health passports) with ITN 
stickers in place
10 9 ((90%)
Patients who slept under the 
ITN the previous night
15 11 (73%)
Number of persons sleeping 
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standardised monitoring tools (ITN registers, ART 
registers and ART master cards), and this must be 
checked during routine supervisory visits
Parallel recording systems with different numbers 
to the ART register and patient master card should 
be discouraged
ITN registers must record all persons (ART 
patients and health care workers) who receive an 
ITN in order to reduce the number of  ITNs that 
are not accounted for
The cumulative numbers of  patients given ITN 
stickers should be recorded at each routine quarterly 
ART supervision and monitoring visit carried out 
by the HIV Unit and its partners.
Formal information education and communication 
(IEC) materials on malaria and use of  ITNs should be 
produced for ART clinic staff  and for ART patients
A formal in-service training module should be developed 
for ITNs, that is used for ART clinic staff  during the 
annual ART refresher trainings
Logistical issues for ITN procurement, distribution and 
storage on a national level will need to be addressed. ART 
drugs in Malawi are distributed through a parallel system 
to assure consistent availability of  ART, and to date, 
Malawi has not experienced a stock-out of  ART drugs. 
Decisions on how ITNs are procured and distributed 
will need to be reached in order to potentiate national 
scale-up for HIV-infected individuals, ideally leveraging 
procurement and supply chain systems developed 
for GFATM- and PMI-supported ITN distribution 
programs as much as possible.
Having shown that ITN distribution from ART clinics is 
feasible, it is now imperative to undertake national roll-out of  
the initiative. The key components for national roll-out are 
shown in Table 3. As of  the end of  2006, we expect about 
60,000 patients to be alive and taking ART at 104 public 
sector health facilities in the country, and during 2007 an 
additional 45,000 patients are expected to start ART. Thus, in 
planning the first year of  national roll-out, a program budget 
will have to be made for 105,000 – 115,000 patients. At a 
unit cost of  about $4.50 per long-lasting ITN, this would 
amount to $450,000 - $495,000. These funds have not been 







the U.S. President’s Malaria Initiative and Malawi’s funding 
from Global Fund against AIDS, TB and Malaria for HIV 
services.19,20 An ongoing source of  funding will need to be 
identified.
ITNs are especially important for children and pregnant 
women in malaria endemic areas, and their use by all of  those 
at risk of  malaria will contribute to community-wide effects 
when high coverage is achieved.17 For the reasons already 
discussed, ITNs may have an additional important role to 
play in HIV-infected persons in preventing severe malaria 
disease and in mitigating the course and transmission of  
HIV.1 Targetting of  ITNs to HIV-infected persons through 
ART clinics allows a structured delivery of  this intervention 
and, because patient outcomes are monitored every quarter, 
it also allows a way to monitor the effectiveness of  such an 
intervention.
In resource-constrained environments such as Malawi, 
provision of  comprehensive HIV care is being rolled out 
through an incremental approach. Non- ART interventions 
such as cotrimoxazole prophylaxis and ITNs, making use 
of  existing program infrastructure, are feasible, will likely 
reduce morbidity and mortality, and may augment broader 
HIV prevention efforts.
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Table 3: Key components for national roll-out of  ITNs in ART 
clinics
Knowledge of the number of ART clinics and the number of 
patients alive and on ART at each of these clinics at the end of 
2006 (data obtained from national quarterly ART reports)
Knowledge of the number of patients to be started on ART 
during the year 2007 (data obtained from disease burden 
classification of ART sites)
Printing of stationery for ITN stickers and ITN Registers to 
complement the ART monitoring tools already in use in the 
clinics
Development of a short training module on distribution and 
monitoring of ITNs to be used during ART refresher training
Development and printing of IEC materials for health workers 
and patients on the value of ITNs
Budget with timeline for ITN roll-out
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